Skip to main content

Tekla Healthcare Investors (HQH) Stock Analysis

SellModerate Confidence

Financial Services · Asset Management

Sell if holding. Engine safety override at $19.70: Quality below floor (3.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10. Specifically: Below-average business quality.

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical... Read more

$19.70-0.7% A.UpsideScore 5.8/10#40 of 109 Asset Management
Stop $19.02Target $19.59(resistance)A.R:R 0.0:1

Sell if holding. Engine safety override at $19.70: Quality below floor (3.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10. Specifically: Below-average business quality. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.8/10, moderate confidence.

Passes 6/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear). Suitability: aggressive.

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.7 < 4.0)

Key Metrics

P/E (TTM)12.1
P/E (Fwd)
Mkt Cap$1.1B
EV/EBITDA
Profit Mgn1309.0%
ROE9.2%
Rev Growth-48.7%
Beta0.73
Dividend12.92%
Rating analysts

Quality Signals

Piotroski F4/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker·3 ceiling hits

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Roa
0.0
Operating Margin
0.0
Roe
3.1
Current Ratio
3.1
Piotroski F
4.4
Moat
5.0
Gross Margin
10.0
No competitive moat
GatesMomentum 4.8<5.5 (soft — BUY_NOW allowed but watch)A.R:R UPSIDE_EXHAUSTED (upside=0.0%)Momentum 4.8>=4.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARSuitability: Aggressive
RSI
65 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $17.92Resistance $19.99

Price Targets

$19
$20
A.Upside-0.6%
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.7 < 4.0)

Earnings

We could not retrieve earnings history for HQH.
The company may be recently listed, pre-revenue, or its beat/miss record wasn't available from our source this run. Earnings signals feed the Growth and Catalyst score dimensions — absence here doesn't affect other dimensions.

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is HQH stock a buy right now?

Sell if holding. Engine safety override at $19.70: Quality below floor (3.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.8/10. Specifically: Below-average business quality. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $19.02. Score 5.8/10, moderate confidence.

What is the HQH stock price target?

Take-profit target: $19.59 (-0.7% upside). Prior stop was $19.02. Stop-loss: $19.02.

What are the risks of investing in HQH?

Quality below floor (3.7 < 4.0).

Is HQH overvalued or undervalued?

Tekla Healthcare Investors trades at a P/E of 12.1 (forward N/A). TrendMatrix value score: 9.4/10. Verdict: Sell.

0
What does Tekla Healthcare Investors do?Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in...

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

Related stocks: ETG (Eaton Vance Tax-Advantaged Glob) · CET (11017) · JHG (Janus Henderson Group plc) · AOD (Aberdeen Total Dynamic Dividend) · CRF (33138)